WEBINAR: After the first JCA reports: How should comparative effectiveness be assessed?

Leading researchers discuss what the first Joint Clinical Assessment reports reveal about comparative evidence, and why JCA needs clearer guidance on how to assess it..

GLOBE Final Rule

MFN update with Tim Wright, Genesis Research Group.

Watch here

EVIDENCE INSIGHTS: From more data to better decisions

How fit-for-purpose data turns evidence complexity into decision-ready insights.

Explore here

WEBINAR – From scoping to systematic: Choosing the right literature review for your evidence needs

Navigate the literature review spectrum and gain practical insight into selecting the most appropriate review approach for your evidence needs.

WEBINAR: Can HEOR prove its own value?

A discussion with the ROI of HEOR Working Group representatives.

Registry-enabled pharmacovigilance: Building fit-for-purpose PASS through scientific partnerships

Melissa Moore-Clingenpeel (Thermo Fisher Scientific) explores how independent prospective registries complement secondary-use RWE.

Read here

HOME
NEWS
FEATURES
TOPICS
EVENTS
ABOUT
SPONSORSHIP

Share on

Facebook
X
LinkedIn
Reddit
Bluesky

News

23 Oct 2026

Duke-Margolis launches dashboard tracking registry use in FDA decision-making
22 Oct 2026

Oracle and AstraZeneca partner to advance AI and real-world data in clinical trials

Webinars

24 Aug 2026

WEBINAR: Parent-administered pediatric blood collection at home: the RedDrop ONE study – December 8, 2026
25 Aug 2026

WEBINAR: From scoping to systematic: Choosing the right literature review for your evidence needs – VIEW ON DEMAND

EDITORIALS

26 Oct 2026

From defining value to reshaping evidence: What to expect from the ISPOR Europe 2026 plenary sessions
22 Oct 2026

Defining the role of RWD in early access programs – Insights from the 5th Operationalise: Early Access Programmes Summit Europe

EXPERT INSIGHTS

5 Oct 2026

VIDEO: GLOBE Final Rule with Tim Wright, Genesis Research Group
5 Oct 2026

Patti's People - Patti Peeples speaks with Rob Abbott

Interested in learning more about our sponsorship opportunities?

Click here

SPOTLIGHTS

Most-Favored-Nation

8 Oct 2026

PhRMA challenges GLOBE drug pricing rule as lawsuit raises questions over QALY-based benchmarks
5 Oct 2026

VIDEO: GLOBE Final Rule with Tim Wright, Genesis Research Group
1 Oct 2026

CMS finalizes GLOBE with new drug exclusions and lower projected savings

JCA in Europe

16 Oct 2026

World Orphan Drug Congress Europe 2026: Previewing the discussions on evidence, HTA and access
9 Oct 2026

European Commission targets unmet cardiovascular need with first medical devices selected for JCA
8 Oct 2026

Editor’s highlights from the Journal of Comparative Effectiveness Research – October 2026

From more data to better decisions

14 Sep 2026

VIDEO – Fit-for-purpose data, decision-ready insights: A conversation with Narasimha Kumar and Tobi Oremulé, BC Platforms
14 Sep 2026

Partner feature: Building a reusable evidence foundation for confident decision-making
14 Sep 2026

Infographic – How fit-for-purpose data turns evidence complexity into decision-ready insight

Interested in the Journal of Comparative Effectiveness Research?

Click here

FEATURED TOPICS

Health Economics

26 Oct 2026

From defining value to reshaping evidence: What to expect from the ISPOR Europe 2026 plenary sessions
19 Oct 2026

Event preview: 14th IMPACCT Real-World Evidence Summit
19 Oct 2026

The methods were never the problem: Mark Sculpher on politics, opportunity cost and the future of HTA

Health Technology Assessment

26 Oct 2026

From defining value to reshaping evidence: What to expect from the ISPOR Europe 2026 plenary sessions
21 Oct 2026

DIA’s 2026 Real-World Evidence Conference daily round-ups: Day 2
19 Oct 2026

The methods were never the problem: Mark Sculpher on politics, opportunity cost and the future of HTA

Real-World Evidence

23 Oct 2026

Duke-Margolis launches dashboard tracking registry use in FDA decision-making
22 Oct 2026

Oracle and AstraZeneca partner to advance AI and real-world data in clinical trials
22 Oct 2026

Defining the role of RWD in early access programs – Insights from the 5th Operationalise: Early Access Programmes Summit Europe

Market Access

22 Oct 2026

Defining the role of RWD in early access programs – Insights from the 5th Operationalise: Early Access Programmes Summit Europe
21 Oct 2026

DIA’s 2026 Real-World Evidence Conference daily round-ups: Day 2
19 Oct 2026

The methods were never the problem: Mark Sculpher on politics, opportunity cost and the future of HTA

WEBINAR: After the first JCA reports: How should comparative effectiveness be assessed?

GLOBE Final Rule

EVIDENCE INSIGHTS: From more data to better decisions

WEBINAR – From scoping to systematic: Choosing the right literature review for your evidence needs

WEBINAR: Can HEOR prove its own value?

Registry-enabled pharmacovigilance: Building fit-for-purpose PASS through scientific partnerships

News

Duke-Margolis launches dashboard tracking registry use in FDA decision-making

Oracle and AstraZeneca partner to advance AI and real-world data in clinical trials

Webinars

WEBINAR: Parent-administered pediatric blood collection at home: the RedDrop ONE study – December 8, 2026

WEBINAR: From scoping to systematic: Choosing the right literature review for your evidence needs – VIEW ON DEMAND

EDITORIALS

From defining value to reshaping evidence: What to expect from the ISPOR Europe 2026 plenary sessions

Defining the role of RWD in early access programs – Insights from the 5th Operationalise: Early Access Programmes Summit Europe

EXPERT INSIGHTS

VIDEO: GLOBE Final Rule with Tim Wright, Genesis Research Group

Patti's People - Patti Peeples speaks with Rob Abbott

SPOTLIGHTS

PhRMA challenges GLOBE drug pricing rule as lawsuit raises questions over QALY-based benchmarks

VIDEO: GLOBE Final Rule with Tim Wright, Genesis Research Group

CMS finalizes GLOBE with new drug exclusions and lower projected savings

World Orphan Drug Congress Europe 2026: Previewing the discussions on evidence, HTA and access

European Commission targets unmet cardiovascular need with first medical devices selected for JCA

Editor’s highlights from the Journal of Comparative Effectiveness Research – October 2026

VIDEO – Fit-for-purpose data, decision-ready insights: A conversation with Narasimha Kumar and Tobi Oremulé, BC Platforms

Partner feature: Building a reusable evidence foundation for confident decision-making

Infographic – How fit-for-purpose data turns evidence complexity into decision-ready insight

From defining value to reshaping evidence: What to expect from the ISPOR Europe 2026 plenary sessions

Event preview: 14th IMPACCT Real-World Evidence Summit

The methods were never the problem: Mark Sculpher on politics, opportunity cost and the future of HTA

From defining value to reshaping evidence: What to expect from the ISPOR Europe 2026 plenary sessions

DIA’s 2026 Real-World Evidence Conference daily round-ups: Day 2

The methods were never the problem: Mark Sculpher on politics, opportunity cost and the future of HTA

Duke-Margolis launches dashboard tracking registry use in FDA decision-making

Oracle and AstraZeneca partner to advance AI and real-world data in clinical trials

Defining the role of RWD in early access programs – Insights from the 5th Operationalise: Early Access Programmes Summit Europe

Defining the role of RWD in early access programs – Insights from the 5th Operationalise: Early Access Programmes Summit Europe

DIA’s 2026 Real-World Evidence Conference daily round-ups: Day 2

The methods were never the problem: Mark Sculpher on politics, opportunity cost and the future of HTA